Skip to main content
. 2017 Jul 1;25(13):3471–3482. doi: 10.1016/j.bmc.2017.04.037

Fig. 3.

Fig. 3

Schematic representation of the fragment elaboration carried out around 1 to develop a lead fragment to inhibit CK2.